Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;

Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients Antonio Franco; Domingo Hernandez; Sofia Zarraga; Ana Sanchez Fructuoso; Marta Crespo; Auxiliadora Mazuecos; Carmen Diaz Corte; Alberto Rodriguez Benot; Juan Carlos Ruiz; Isabel Beneyto;

Comparative efficacy of three regimens (cyclosporine, tacrolimus, and cyclophosphamide) combined with steroids for the treatment of idiopathic membranous nephropathy Chen Ruo-ji; Xing Fang; Du Zhen-shuang; Zhang Yu-lin; Zheng Zi-li; Lin Wei-yuan;